Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2004 1
2006 7
2007 2
2008 1
2013 1
2015 2
2016 4
2017 3
2018 7
2019 10
2020 12
2021 13
2022 16
2023 15
2024 6
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

93 results

Results by year

Filters applied: . Clear all
Page 1
Deep Learning Modeling to Differentiate Multiple Sclerosis From MOG Antibody-Associated Disease.
Cortese R, Sforazzini F, Gentile G, de Mauro A, Luchetti L, Amato MP, Apóstolos-Pereira SL, Arrambide G, Bellenberg B, Bianchi A, Bisecco A, Bodini B, Calabrese M, Camera V, Celius EG, de Medeiros Rimkus C, Duan Y, Durand-Dubief F, Filippi M, Gallo A, Gasperini C, Granziera C, Groppa S, Grothe M, Gueye M, Inglese M, Jacob A, Lapucci C, Lazzarotto A, Liu Y, Llufriu S, Lukas C, Marignier R, Messina S, Müller J, Palace J, Pastó L, Paul F, Prados F, Pröbstel AK, Rovira À, Rocca MA, Ruggieri S, Sastre-Garriga J, Sato DK, Schneider R, Sepulveda M, Sowa P, Stankoff B, Tortorella C, Barkhof F, Ciccarelli O, Battaglini M, De Stefano N; MAGNIMS Study Group. Cortese R, et al. Among authors: lapucci c. Neurology. 2025 Sep 23;105(6):e214075. doi: 10.1212/WNL.0000000000214075. Epub 2025 Sep 4. Neurology. 2025. PMID: 40906978 Free PMC article.
Ocrelizumab in MS patients with persistence of disease activity after alemtuzumab: A multi-center Italian study.
Lapucci C, Frau J, Cocco E, Coghe G, Petracca M, Lanzillo R, Brescia Morra V, Nicoletti CG, Landi D, Marfia G, Vercellino M, Cavalla P, Bianco A, Mirabella M, Torri Clerici V, Tomas E, Ferrò MT, Grossi P, Nozzolillo A, Moiola L, Zaffaroni M, Ronzoni M, Pinardi F, Novi G, Cellerino M, Uccelli A, Inglese M. Lapucci C, et al. Mult Scler. 2024 Aug;30(9):1151-1162. doi: 10.1177/13524585241266509. Epub 2024 Aug 14. Mult Scler. 2024. PMID: 39143825
Molecular imaging of multiple sclerosis: from the clinical demand to novel radiotracers.
Bauckneht M, Capitanio S, Raffa S, Roccatagliata L, Pardini M, Lapucci C, Marini C, Sambuceti G, Inglese M, Gallo P, Cecchin D, Nobili F, Morbelli S. Bauckneht M, et al. Among authors: lapucci c. EJNMMI Radiopharm Chem. 2019 Apr 8;4(1):6. doi: 10.1186/s41181-019-0058-3. EJNMMI Radiopharm Chem. 2019. PMID: 31659498 Free PMC article. Review.
The "central vein sign" to differentiate multiple sclerosis from migraine.
Silvestri G, Roccatagliata L, Tazza F, Schiavi S, Coccia A, Bandettini Di Poggio M, Cellerino M, Signori A, Finocchi C, Uccelli A, Inglese M, Lapucci C. Silvestri G, et al. Among authors: lapucci c. Headache. 2025 Apr;65(4):558-567. doi: 10.1111/head.14902. Epub 2025 Jan 20. Headache. 2025. PMID: 39834045
The early effect of induction versus continuous therapies in active multiple sclerosis: a multimodal study on the first course of cladribine versus fingolimod.
Sirito T, Cipriano E, Lapucci C, Boccia VD, Panzera I, Uccelli A, Capello E, Cellerino M, Inglese M, Boffa G. Sirito T, et al. Among authors: lapucci c. Mult Scler Relat Disord. 2025 Aug 9;103:106661. doi: 10.1016/j.msard.2025.106661. Online ahead of print. Mult Scler Relat Disord. 2025. PMID: 40850227 Free article.
Rapid, scalable assessment of SARS-CoV-2 cellular immunity by whole-blood PCR.
Schwarz M, Torre D, Lozano-Ojalvo D, Tan AT, Tabaglio T, Mzoughi S, Sanchez-Tarjuelo R, Le Bert N, Lim JME, Hatem S, Tuballes K, Camara C, Lopez-Granados E, Paz-Artal E, Correa-Rocha R, Ortiz A, Lopez-Hoyos M, Portoles J, Cervera I, Gonzalez-Perez M, Bodega-Mayor I, Conde P, Oteo-Iglesias J, Borobia AM, Carcas AJ, Frías J, Belda-Iniesta C, Ho JSY, Nunez K, Hekmaty S, Mohammed K, Marsiglia WM, Carreño JM, Dar AC, Berin C, Nicoletti G, Della Noce I, Colombo L, Lapucci C, Santoro G, Ferrari M, Nie K, Patel M, Barcessat V, Gnjatic S, Harris J, Sebra R, Merad M, Krammer F, Kim-Schulze S, Marazzi I, Bertoletti A, Ochando J, Guccione E. Schwarz M, et al. Among authors: lapucci c. Nat Biotechnol. 2022 Nov;40(11):1680-1689. doi: 10.1038/s41587-022-01347-6. Epub 2022 Jun 13. Nat Biotechnol. 2022. PMID: 35697804 Free PMC article.
93 results